Objetivo
Over 50% of the 4 million European cancer patients experience crippling fatigue as side effect of their illness and the onerous treatments involved. The severe fatigue lasts for up to 10 years in 30% of cancer survivors, who experience fatigue daily, affecting their activities and quality of life.
Tired of Cancer BV, a privately owned spin-out company of the Helen Dowling Institute is a young international company that has developed a digital application that includes beneficial therapeutic elements to improve to lives of millions fatigued cancer patients. Tired of Cancer BV’s business strategy is to develop an integrated platform that offers remote therapy through the clinic as well as through digital vendors. The overall aim of Tired of Cancer BV is to implement their digital therapy as the clinical golden standard for the treatment of Cancer Related Fatigue.
At the start of mPOWER, Tired of Cancer BV provides its users with a smartphone or tablet application based on decades of scientific insights and clinical best-practice. The deliverables for mPOWER include (i) a market-ready App with proven effectivity, (ii) several innovations in the TiredofCancer tools to improve on the use in clinical practice and (iii) a multi-facetted and expansive marketing and commercialization strategy directed at the EU market.
The TiredofCancer tool has three elements that uniquely positions the company to address the problem that cancer related fatigue poses to society and generate fast growth.
(i) The TiredofCancer tool has proven efficacy in the clinic as well as in a web-based environment.
(ii) The App is easily accessible for any end user with a smartphone or tablet.
(iii) The tool will be integrated into clinical practice to provide specialists with guidelines to help tired patients.
Thus, Tired of Cancer BV provides a complete and widely accessible digital medicine to address cancer-related fatigue, easily available from the App-store and in clinical practices.
Ámbito científico
CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.
CORDIS clasifica los proyectos con EuroSciVoc, una taxonomía plurilingüe de ámbitos científicos, mediante un proceso semiautomático basado en técnicas de procesamiento del lenguaje natural.
- social scienceseconomics and businessbusiness and managementbusiness models
- medical and health sciencesclinical medicineoncology
- engineering and technologyelectrical engineering, electronic engineering, information engineeringinformation engineeringtelecommunicationsmobile phones
- social scienceseconomics and businessbusiness and managementemployment
- social scienceseconomics and businesseconomicshealth economics
Programa(s)
- H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme
- H2020-EU.3.1.4. - Active ageing and self-management of health
- H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
- H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
- H2020-EU.3.1.6. - Health care provision and integrated care
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-SMEINST-2-2016-2017
Régimen de financiación
SME-2 - SME instrument phase 2Coordinador
3581 ME Utrecht
Países Bajos
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.